These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31564180)

  • 1. The pragmatic role of FEF
    Ciprandi G; Cirillo I
    Expert Rev Respir Med; 2019 Dec; 13(12):1147-1151. PubMed ID: 31564180
    [No Abstract]   [Full Text] [Related]  

  • 2. Spirometry in children with asthma and/or allergic rhinitis: comparison of FEF25-75% with the standard measures.
    Eke Gungor H; Sahiner UM; Altuner Torun Y
    Minerva Pediatr; 2019 Apr; 71(2):103-109. PubMed ID: 26365818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced forced expiratory flow between 25% and 75% of vital capacity in children with allergic rhinitis without asthmatic symptoms.
    Lee JS; Park SH; Kim HH; Ahn SH; Kim E; Kim S; Yoon W; Yoo Y
    J Asthma; 2023 May; 60(5):1024-1030. PubMed ID: 36093643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Practical Role of FEF
    Cirillo I; Schiavetti I; Ricciardolo FLM; Miraglia Del Giudice M; Tosca MA; Ciprandi G
    Am J Rhinol Allergy; 2023 Sep; 37(5):571-574. PubMed ID: 37309103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired FEF25-75 values may predict bronchial reversibility in allergic children with rhinitis or asthma.
    Ciprandi G; Capasso M; Leonardi S; Lionetti E; La Rosa M; Salpietro C; Miraglia Del Giudice M; Cirillo I; Tosca M; Marseglia GL
    J Biol Regul Homeost Agents; 2012; 26(1 Suppl):S19-25. PubMed ID: 22691246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of FEF25-75% Impairment with Bronchial Hyperresponsiveness and Airway Inflammation in Subjects with Asthma-Like Symptoms.
    Malerba M; Radaeli A; Olivini A; Damiani G; Ragnoli B; Sorbello V; Ricciardolo FL
    Respiration; 2016; 91(3):206-14. PubMed ID: 26855322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired FEF25-75 may predict high exhaled nitric oxide values in children with allergic rhinitis and/or asthma.
    Ciprandi G; Tosca MA; Cirillo I; Lionetti E; Leonardi S; Miraglia Del Giudice M; La Rosa M; Salpietro A; Capasso M; Marseglia GL
    J Biol Regul Homeost Agents; 2012; 26(1 Suppl):S27-33. PubMed ID: 22691247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FEF25-75% and the clinical diagnosis of asthma.
    Alberts WM; Ferris MC; Brooks SM; Goldman AL
    Ann Allergy; 1994 Sep; 73(3):221-5. PubMed ID: 8092555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective and objective assessments of seasonal effect in children with seasonal allergic rhinitis.
    Ginis T; Bostanci I; Ozmen S; Misirlioglu ED; Dogru M; Duman H
    Int J Pediatr Otorhinolaryngol; 2015 Mar; 79(3):405-10. PubMed ID: 25604260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FEF(25-75) might be a predictive factor for bronchial inflammation and bronchial hyperreactivity in adolescents with allergic rhinitis.
    Ciprandi G; Tosca MA; Castellazzi AM; Cairello F; Salpietro C; Arrigo T; Miraglia Del Giudice M
    Int J Immunopathol Pharmacol; 2011 Oct; 24(4 Suppl):17-20. PubMed ID: 22032781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index is related with bronchial function and reversibility in children with allergic rhinitis and asthma.
    Ciprandi G; Brambilla I; Tosca MA; Arrigo T; Salpietro A; Leonardi S; La Rosa M; Marseglia GL
    Int J Immunopathol Pharmacol; 2011 Oct; 24(4 Suppl):21-4. PubMed ID: 22032782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of FEF25-75 in managing children with newly-diagnosed asthma in clinical practice.
    Ciprandi G; Tosca MA; Schiavetti I; Olcese R; Miraglia Del Giudice M
    Acta Biomed; 2022 Aug; 93(4):e2022276. PubMed ID: 36043974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FEF
    Qin R; An J; Xie J; Huang R; Xie Y; He L; Xv H; Qian G; Li J
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3649-3659.e6. PubMed ID: 34214706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis.
    Marseglia GL; Cirillo I; Vizzaccaro A; Klersy C; Tosca MA; La Rosa M; Marseglia A; Licari A; Leone M; Ciprandi G
    Allergy Asthma Proc; 2007; 28(1):74-8. PubMed ID: 17390762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the asthma visual analog scale relate to the Asthma Control Questionnaire?
    Jabbal S; Lipworth BJ
    Ann Allergy Asthma Immunol; 2018 May; 120(5):533-535. PubMed ID: 29573960
    [No Abstract]   [Full Text] [Related]  

  • 16. Body mass index, respiratory function and bronchial hyperreactivity in allergic rhinitis and asthma.
    Ciprandi G; Pistorio A; Tosca M; Ferraro MR; Cirillo I
    Respir Med; 2009 Feb; 103(2):289-95. PubMed ID: 18818065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of bronchial hyperresponsiveness in subjects with rhinitis.
    Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Leto-Barone MS; Napoli N; Di Fede G; Rini GB
    Int J Immunopathol Pharmacol; 2005; 18(4):715-22. PubMed ID: 16388720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High exhaled nitric oxide levels may predict bronchial reversibility in allergic children with asthma or rhinitis.
    Ciprandi G; Tosca MA; Capasso M
    J Asthma; 2013 Feb; 50(1):33-8. PubMed ID: 23157515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forced midexpiratory flow between 25% and 75% of forced vital capacity is associated with long-term persistence of asthma and poor asthma outcomes.
    Siroux V; Boudier A; Dolgopoloff M; Chanoine S; Bousquet J; Gormand F; Just J; Le Moual N; Nadif R; Pison C; Varraso R; Matran R; Pin I
    J Allergy Clin Immunol; 2016 Jun; 137(6):1709-1716.e6. PubMed ID: 26688518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of allergic rhinitis on asthma: effects on bronchodilation testing.
    Ciprandi G; Cirillo I; Pistorio A; La Grutta S; Tosca M
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):42-6. PubMed ID: 18681083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.